Información del producto
- Portamycin
- 2-Pyrrolidineacetamide, 4-[(2E,4E,6R)-6-[(1R,2′R,3R,4S,5R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2′-oxiran]-3-yl]-1-hydroxy-4-methyl-2,4-heptadien-1-ylidene]-N,α-dimethyl-3,5-dioxo-1-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-, (αS,2S,4E)-
- 3-Pyrroline-2-acetamide, 4-[6-(1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2′-oxiran]-3-yl)-4-methyl-2,4-heptadienoyl]-3-hydroxy-N,α-dimethyl-5-oxo-1-(tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-
- (αS,2S,4E)-4-[(2E,4E,6R)-6-[(1R,2′R,3R,4S,5R)-1,4-Dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2′-oxiran]-3-yl]-1-hydroxy-4-methyl-2,4-heptadien-1-ylidene]-N,α-dimethyl-3,5-dioxo-1-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-2-pyrrolidineacetamide
- 2-Pyrrolidineacetamide, 4-[(2E,4E,6R)-6-[(1R,2′R,3R,4S,5R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2′-oxiran]-3-yl]-1-hydroxy-4-methyl-2,4-heptadienylidene]-N,α-dimethyl-3,5-dioxo-1-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-, (αS,2S,4E)-
Streptolydigin inhibits RNA synthesis by binding to RNA polymerase and does not inhibit eukaryotic RNA polymerases.
Propiedades químicas
Consulta técnica sobre: TM-T16945 Streptolydigin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.